Clinical Trial Update: ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for ImmunoTEP with 68-Ga in metastatic colorectal cancer. Study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ImmunoTEP with 68-Ga

Snippet

Sponsor: Nantes University Hospital | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED